
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES35
A study including patients from the Fremantle Diabetes Study (FDS) cohort46 over 5 years of
follow-up did not find any difference in HbA1c or in fasting plasma glucose, either overall or
within treatment groups in patients who used SMBG than those who did not (p=0.05). There
were also no differences in HbA1c or FPG between SMBG adherent and non-adherent users by
treatment group (p=0.09). Level 2+

[@Davis_2007]

